Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Waystar
Every one of those 1 sits in a single category, market-trends. Of the tracked stories, 1 of 1 also mention Needham & Company LLC, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.3 for that window. Each story carries 3 original sources on average, compared with 2.2 for the broader beat in this window. We currently track 1 SaaS story that mention Waystar, all published on February 19, 2026.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 52 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Waystar. Shared-story counts are live from our verified record — not editorial picks.
Waystar (NASDAQ: WAY) is facing a divergent outlook from major analysts as Needham & Company LLC lowered its price target to $33.00, while Truist Financial established a more optimistic $38.00 target. These updates come as the healthcare payments SaaS provider navigates a complex post-IPO landscape characterized by shifting provider spending patterns.